期刊文献+

先导化合物结构优化策略(三)——通过化学修饰改善水溶性 被引量:19

Lead compound optimization strategy(3)——structure modification strategies for improving water solubility
原文传递
导出
摘要 水溶性是有机小分子药物极为重要的物理化学性质,也是小分子药物研发过程中的关键问题之一。良好的水溶性有助于药效的发挥和药代动力学性质的改善。在药物化学领域,通过化学结构修饰方法改善药物的水溶性,是从溶解的本质上考虑和解决问题的基本方法。本文综述了通过化学结构修饰改善水溶性的基本策略,包括成盐修饰、引入极性基团、降低脂溶性、构象优化、前药修饰等。 Water solubility is an essential physical chemistry property of organic small molecule drug and is also a very important issue in drug discovery. Good water solubility often leads to a good drug potency and pleasant pharmacokinetic profiles. To improve water solubility, structure modification is a straight and effective way based on the theory of water solubility. This review summarized valid structure modification strategies for improving water solubility including salt formation, polar group introduction, liposolubility reduction, conformation optimization and prodrug.
出处 《药学学报》 CAS CSCD 北大核心 2014年第9期1238-1247,共10页 Acta Pharmaceutica Sinica
基金 国家杰出青年科学基金资助项目(81025017)
关键词 水溶性 结构修饰 前药 先导化合物优化 water solubility structure modification prodrug lead optimization
  • 相关文献

参考文献8

二级参考文献167

  • 1郭彦伸,褚凤鸣,郭宗儒.距离比较法构建表皮生长因子受体抑制剂的药效团模型[J].中国医学科学院学报,2004,26(4):379-384. 被引量:2
  • 2陈志卫,胡永洲,吴好好,蒋惠娣.黄酮类化合物的合成及其血管舒张作用[J].药学学报,2005,40(11):1001-1007. 被引量:14
  • 3Gardner CR, Almarsson O, Chen H, et al. Application of high throughput technologies to drug substance and drug product development [J]. Comput Chem Eng, 2004, 28(6-7) : 943-953.
  • 4Balbach S, Korn C. Pharmaceutical evaluation of early development candidates "the 100 mg-approach" [J]. Int J Pharm, 2004, 275 (1-2) : 1-12.
  • 5Li S, Wong S, Sethia S, et al. Investigation of solubility and dissolution of a free base and two different salt forms as a function ofpH [J]. Pharm Res, 2005, 22 (4) : 628-635.
  • 6Serajuddin AT. Salt formation to improve drug solubility [J]. Adv Drug Deliv Rev, 2007, 59 (7): 603-616.
  • 7Berge SM, Bighley LD, Monkhouse DC. Pharmaceutical salts[J]. JPharm Sci, 1977, 66(1): 1-19.
  • 8Banerjee R, Bhatt PM, Ravindra NV, et al. Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities [J]. Cryst Growth Des, 2005, 5 (6) : 2299-2309.
  • 9Bastin RJ, Bowker MJ, Slater BJ. Salt selection and optimisation procedures for pharmaceutical new chemical entities [J]. Org Pro Res Dev, 2000, 4 (5) : 427-435.
  • 10Lam KW, Xu J, Ng KM, et al. Pharmaceutical salt formation guided by phase diagrams [J]. Ind Eng Chem Res, 2010, 49 (24) : 12503-12512.

共引文献80

同被引文献147

引证文献19

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部